Drop Down MenusCSS Drop Down MenuPure CSS Dropdown Menu
Alternative Text Alternative Text Alternative Text Alternative Text
Survivor of US Drone Attack:
Obama Belongs on List of World's Tyrants

Poisoning Black Cities: Corporate Campaign to Ethnically Cleanse US Cities Massive Marches in Poland
Against Authoritarian Threat of Far-Right
Ethiopia’s Invisible Crisis: Land Rights Activists Kidnapped and Tortured

Global Perspectives Now Global Perspectives Now

Ebola Serum Politics - Pt 3: West Africans Are Finally Receiving The Same Experimental Ebola Drug Given To Europeans

Photo from European Commission DG ECHO.
Photo from European Commission DG ECHO.
By Tara Culp-Ressler
Two doctors in Liberia will be the first Africans to receive an experimental treatment for Ebola that has been previously only been used on two Americans and a Spaniard, Liberian officials announced on Monday. The decision comes on the heels of a World Health Organization panel’s ruling that it’s ethical to use the untested drug in an attempt to contain the deadly Ebola outbreak, which has claimed more than 1,000 lives in several West African nations.

There’s no cure and no vaccine for the Ebola virus, which is currently killing about 60 percent of the people who become infected with it. But an experimental Ebola drug called ZMapp, manufactured by a U.S. biotech company but not yet approved by the government, has shown promise in treating animals infected with the virus.

ZMapp was quickly given to the three Europeans who became infected with the disease while abroad — sparking concerns about the disparities in treatment emerging along geographic, economic, and racial lines. Now, the U.S. government is helping connect Liberian officials with the drug maker to ship doses into the country, but it’s still unclear how much of the limited supply Liberia will receive.

Read More

No comments:

Related Posts Plugin for WordPress, Blogger...